Publicaciones en colaboración con investigadores/as de Hospital General Universitario Gregorio Marañón (23)

2020

  1. Atherogenic Dyslipidaemia 2019. Consensus document of the Atherogenic Dyslipidaemia Group of the Spanish Arteriosclerosis Society

    Clinica e Investigacion en Arteriosclerosis, Vol. 32, Núm. 3, pp. 120-125

  2. Triglycerides, HDL cholesterol and atherogenic dyslipidaemia in the 2019 European guidelines for the management of dyslipidaemias

    Clinica e Investigacion en Arteriosclerosis, Vol. 32, Núm. 5, pp. 209-218

2019

  1. Non-HDL cholesterol as a therapeutic goal

    Clinica e Investigacion en Arteriosclerosis, Vol. 31, pp. 28-33

  2. Residual cardiovascular risk of lipid origin. Components and pathophysiological aspects

    Clinica e Investigacion en Arteriosclerosis

  3. Standards for global cardiovascular risk management arteriosclerosis

    Clinica e Investigacion en Arteriosclerosis, Vol. 31, pp. 1-43

2018

  1. COSMIC project: Consensus on the objectives of the metabolic syndrome in clinic

    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol. 11, pp. 683-697

  2. Fibrates in primary prevention of cardiovascular disease. Comments on the results of a systematic review of the Cochrane Collaboration

    Clinica e Investigacion en Arteriosclerosis, Vol. 30, Núm. 4, pp. 188-192

2017

  1. Consensus on the Statin of Choice in Patients with Impaired Glucose Metabolism: Results of the DIANA Study

    American Journal of Cardiovascular Drugs, Vol. 17, Núm. 2, pp. 135-142

  2. Enfermedad renal crónica y dislipidemia

    Clinica e Investigacion en Arteriosclerosis

  3. Nonalcoholic fatty liver disease, association with cardiovascular disease and treatment (II). The treatment of nonalcoholic fatty liver disease

    Clinica e Investigacion en Arteriosclerosis

  4. Nonalcoholic fatty liver disease, association with cardiovascular disease and treatment. (I). Nonalcoholic fatty liver disease and its association with cardiovascular disease

    Clinica e Investigacion en Arteriosclerosis

2016

  1. Consenso Delphi sobre el manejo de la dislipidemia en pacientes con alteración del metabolismo de la glucosa: Estudio Diana

    Clinica e Investigacion en Arteriosclerosis, Vol. 28, Núm. 3, pp. 132-140

  2. Delphi consensus on the diagnosis and management of dyslipidaemia in chronic kidney disease patients: A post hoc analysis of the DIANA study

    Nefrologia, Vol. 36, Núm. 6, pp. 679-686

2015

  1. Sindrome metabólico en pacientes con fenotipo clínico de “cintura hipertrigliceridémica”

    Nutricion Hospitalaria, Vol. 32, Núm. 3, pp. 1145-1152

2012

  1. Documento Abordaje de la dislipidemia. Sociedad Española de Arteriosclerosis (parte II)

    Clinica e Investigacion en Arteriosclerosis, Vol. 24, Núm. 1, pp. 40-52

  2. Documento Abordaje de la dislipidemia. Sociedad Española de Arteriosclerosis (parte III)

    Clinica e Investigacion en Arteriosclerosis, Vol. 24, Núm. 2, pp. 102-107

2011

  1. Documento Abordaje de la dislipidemia. Sociedad Española, de Arteriosclerosis (Parte I)

    Clinica e Investigacion en Arteriosclerosis, Vol. 23, Núm. 6, pp. 278-288

  2. Prevalence of metabolic syndrome and cardiovascular disease in a hypertriglyceridemic population

    European Journal of Internal Medicine, Vol. 22, Núm. 2, pp. 177-181

2009

  1. Lipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular prevention

    Vascular Health and Risk Management

2007

  1. Management of dyslipidemia in the metabolic syndrome: Recommendations of the Spanish HDL-forum

    American Journal of Cardiovascular Drugs, Vol. 7, Núm. 1, pp. 39-58